PUBLISHER: Inkwood Research | PRODUCT CODE: 1139193
PUBLISHER: Inkwood Research | PRODUCT CODE: 1139193
The Europe data exchange in healthcare market is set to project a CAGR of 28.10% during the forecast period, 2022-2030. The accelerating digitization initiatives and virtual healthcare treatment like telemedicine offer growth opportunities. However, stringent data protection regulations like General Data Protection Regulation (GDPR) restrict digitization growth, thereby impacting the overall market growth.
Germany, France, Italy, the United Kingdom, Belgium, Poland, and Rest of Europe are assessed for the Europe data exchange in healthcare market growth evaluation. In France, the National Health Strategy 2022 promotes non-digital measure alongside the reinforcement of governance and security and the interoperability with the accelerated roll-out of digital health applications. Also, it encompasses innovations in digital care, particularly telemedicine, and is supplemented by investment programs as per the digital readiness of hospital networks.
Further, the country has launched 'Dossier Medical Partge' (DMP), an interoperable electronic medical record for all French residents. In addition, the rising investments in digital health technologies offer growth opportunities. For instance, Orange, a major private equity sector, invested in the Digital Health 2 (DH2) fund of LBO France, in November 2020.
Belgium is home to a robust healthcare market. It has no legal framework regarding digitization in the healthcare sector. However, the Belgian government is reluctant to accept healthcare digitization. For instance, until recently, the National Council of the Order of Physicians required the presence of both the patient and the physician for patient diagnosis. Such factors drive market growth in these countries.
Some of the prominent market players include: HealthVerity, McKesson Corporation, Medicalchain SA, Longensis, etc.